Abexome Biosciences Private Limited
About Abexome Biosciences Private Limited
Data last updated: 08 March 2026
Abexome Biosciences Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Nadathur Estates Private Limited. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 01 February 2007, the company has been in operation for over 19 years.
Registered with ROC Bangalore under CIN U73100KA2007PTC041611.
Capital: an authorised share capital of ₹1.6 Cr and a paid-up capital of ₹1.15 Cr. It is led by directors Nandan Laxman Sastry and Suri Venkatachalam.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Nadathur Place 3Rd Floor Plot No. 23 8Th Main Road Jayanagar 3Rd Block, Bangalore, Karnataka, India – 560011.
It operates as a subsidiary of Nadathur Estates Private Limited.
The company is associated with 1 brand - Abexome Bioscience. As per MCA filings, the company has satisfied charges of ₹1.05 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
-
Email*****@*****.com
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered AddressNadathur Place 3Rd Floor Plot No. 23 8Th Main Road Jayanagar 3Rd Block, Bangalore, Karnataka, India – 560011
-
IndustryLife Sciences, Biotechnology
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Abexome Biosciences Private Limited
Abexome Biosciences Private Limited operates one associated brand: Abexome Bioscience. These brands represent Abexome Biosciences Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Operates as a CRO focused on developing antibodies and ELISA assays for biopharmaceuticals and research labs. | abexome.com |
Competitors & Alternatives of Abexome Biosciences Private Limited
Brands and companies operating in the same space as Abexome Biosciences Private Limited include Abingdon Health, SurModics, Eclipse Bio and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Abingdon Health
|
Developer of immunoassays for diagnostic purposes | York, United Kingdom, United Kingdom | 2008 |
SurModics
|
In-vitro diagnostic assays, reagents, and point-of-care devices are manufactured. | Eden Prairie, United States, United States | 1979 |
Eclipse Bio
|
Cell-free immunoassays are developed to identify RNA binding protein targets. | San Diego, United States, United States | 2017 |
Spear Bio
|
Developer of ultrasensitive immunoassays and proteomics platforms for detecting protein biomarkers | Boston, United States, United States | 2021 |
Olink
|
Provider of products and services for human protein biomarker research and development | Uppsala, Sweden, Sweden | 2004 |
Accellix
|
Developer of immunotherapy-based assay delivery platform | San Jose, United States, United States | 2007 |
Virtue Diagnostics
|
An in vitro assay platform is provided for diagnostic solutions. | Suzhou, China, China | 2019 |
US BioTek Laboratories
|
Provider of enzyme-linked immunosorbent assay technology services | Shoreline, United States, United States | 2008 |
RemedyBio
|
Personalized cell-based autologous therapies for anti-tumor applications are provided. | Dublin, Ireland, Ireland | 2017 |
Correlia Biosystems
|
Correlia Biosystems is focused on protein quantification technology. | Berkeley, United States, United States | 2013 |
Auditor Details of Abexome Biosciences Private Limited
Abexome Biosciences Private Limited is audited by BADARI MADHUSUDHAN & SRINIVASAN for the financial year 2019. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| BADARI MADHUSUDHAN & SRINIVASAN | blur-value | blur-value | blur-value |
Board of Directors of Abexome Biosciences Private Limited
Abexome Biosciences Private Limited is currently managed by 2 directors, with 5 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Nandan Laxman Sastry
Also directs:
Consilience Research Advisors Llp, Saptami Technologies Llp, Primevere Properties Llp and 5 more
|
Director | 22 May 2018 | 8 Years 1 Months | Current |
| Suri Venkatachalam | Director | 01 Feb 2007 | 19 Years 5 Months | Current |
Financials of Abexome Biosciences Private Limited FY 2025 filings available
Abexome Biosciences Private Limited reported revenue of ₹- (up ) for FY 2020. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Abexome Biosciences Private Limited
As of FY 2019, Abexome Biosciences Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Abexome Biosciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 2011 | Department of Biotechnology | ₹1.05 Cr | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Abexome Biosciences Private Limited
Abexome Biosciences Private Limited has a workforce of 0 employees as of Mar 28, 2024.
Employee Count & EPFO Data of Abexome Biosciences Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Abexome Biosciences Private Limited
GSTIN & GST Filing Data of Abexome Biosciences Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Abexome Biosciences Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Abexome Biosciences Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Abexome Biosciences Private Limited
MSME Payment Delays by Abexome Biosciences Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Abexome Biosciences Private Limited
Subsidiaries & Group Companies of Abexome Biosciences Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Abexome Biosciences Private Limited with ownership details.
MCA Filings & Documents of Abexome Biosciences Private Limited
MCA Filings & Documents of Abexome Biosciences Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Abexome Biosciences Private Limited
Frequently Asked Questions about Abexome Biosciences Private Limited
Abexome Biosciences Private Limited is an active private limited company in the life sciences sector based in Bangalore, Karnataka, India. It was incorporated on 01 February 2007 (19+ years old) and is registered under CIN U73100KA2007PTC041611.
The current directors of Abexome Biosciences Private Limited are:
The primary industry of Abexome Biosciences Private Limited is life sciences. The company specifically operates in biotechnology. The company is currently active in this sector.
Abexome Biosciences Private Limited can be reached at the registered office: Nadathur Place 3Rd Floor Plot No. 23 8Th Main Road Jayanagar 3Rd Block, Bangalore, Karnataka, India – 560011.
The authorised capital is ₹1.6 Cr, and the paid-up capital is ₹1.15 Cr.
The company has its registered office at Nadathur Place 3Rd Floor Plot No. 23 8Th Main Road Jayanagar 3Rd Block, Bangalore, Karnataka, India – 560011.